European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders

The recent commercialisation of the first disease-modifying drugs for Alzheimer's disease emphasises the need for consensus recommendations on the rational use of biomarkers to diagnose people with suspected neurocognitive disorders in memory clinics. Most available recommendations and guidelin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lancet neurology Jg. 23; H. 3; S. 302 - 312
Hauptverfasser:	Frisoni, Giovanni B, Festari, Cristina, Massa, Federico, Cotta Ramusino, Matteo, Orini, Stefania, Aarsland, Dag, Agosta, Federica, Babiloni, Claudio, Borroni, Barbara, Cappa, Stefano F, Frederiksen, Kristian S, Froelich, Lutz, Garibotto, Valentina, Haliassos, Alexander, Jessen, Frank, Kamondi, Anita, Kessels, Roy PC, Morbelli, Silvia D, O'Brien, John T, Otto, Markus, Perret-Liaudet, Armand, Pizzini, Francesca B, Vandenbulcke, Mathieu, Vanninen, Ritva, Verhey, Frans, Vernooij, Meike W, Yousry, Tarek, Boada Rovira, Mercè, Dubois, Bruno, Georges, Jean, Hansson, Oskar, Ritchie, Craig W, Scheltens, Philip, van der Flier, Wiesje M, Nobili, Flavio
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Elsevier Ltd 01.03.2024 Elsevier Limited
Schlagworte:	Agreements Alzheimer Disease - diagnosis Alzheimer's disease Aphasia Atrophy Basic Medicine Biomarkers Cognition Cognitive ability Consensus Dementia Diagnosis Disease Epilepsy Europe Humans Literature reviews Medical and Health Sciences Medical diagnosis Medical imaging Medicin och hälsovetenskap Medicinska och farmaceutiska grundvetenskaper Memory Neurodegeneration Neurodegenerative diseases Neuroimaging Neurological disorders Neuropsychology Neurosciences Neurovetenskaper Patients Scintigraphy Societies, Scientific Europe
ISSN:	1474-4422, 1474-4465, 1474-4465
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!